Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cibinetide in Prediabetes and Drug-Naive Type 2 Diabetes
NCT01933529Phase 2Unknown
- Start
- Oct 2013
- Primary completion
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cibinetide in prediabetes, type 2 diabetes mellitus (T2DM). Status: unknown.
02
Drugs
cibinetide
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01933529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01933529.